Lv21
160 积分 2021-12-01 加入
Pharmacokinetics and Safety of Single and Multiple Daily Dosing of 75-mg Rimegepant Orally Disintegrating Tablets in Healthy Chinese Adults: A Randomized Placebo-Controlled Trial
2小时前
已完结
A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants
2小时前
已完结
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
1个月前
已完结
Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A phase 2/3 open-label study
1个月前
已完结
A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine
2个月前
已完结
Comparison of New Pharmacologic Agents With Triptans for Treatment of Migraine: A Systematic Review and Meta-analysis
2个月前
已完结
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial
2个月前
已完结
Atogepant for the Preventive Treatment of Migraine
2个月前
已完结
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine
2个月前
已完结
Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials
2个月前
已完结
皖公网安备34019202002308
